NGM Biopharmaceuticals Dirección
Dirección controles de criterios 2/4
El CEO de NGM Biopharmaceuticals' es David Woodhouse , nombrado en Sep 2018, tiene una permanencia de 5.58 años. compensación anual total es $5.93M, compuesta por 10.3% salario y 89.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.14% de las acciones de la empresa, por valor de $179.29K. La antigüedad media del equipo directivo y de la junta directiva es de 1.3 años y 5.6 años, respectivamente.
Información clave
David Woodhouse
Chief Executive Officer (CEO)
US$5.9m
Compensación total
| Porcentaje del salario del CEO | 10.3% |
| Permanencia del CEO | 5.6yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 1.3yrs |
| Promedio de permanencia en la Junta Directiva | 5.6yrs |
Actualizaciones recientes de la dirección
Recent updates
What NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) 32% Share Price Gain Is Not Telling You
Dec 19
We're A Little Worried About NGM Biopharmaceuticals' (NASDAQ:NGM) Cash Burn Rate
Oct 05Some Analysts Just Cut Their NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Estimates
Aug 09Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Could Be Quite Risky
Jun 27NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) Business Is Trailing The Industry But Its Shares Aren't
Apr 17We Think NGM Biopharmaceuticals (NASDAQ:NGM) Needs To Drive Business Growth Carefully
Dec 20NGM Biopharma sinks ~72% after phase 2 trial of its eye degeneration treatment fails
Oct 17NGM Biopharmaceuticals appoints CFO Siobhan Nolan Mangini to the additional role of President
Jun 30NGM Biopharmaceuticals: Eye Disorder Data Due Second Half Of 2022
Jun 21Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth
Jun 15Analysts Are Betting On NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) With A Big Upgrade This Week
May 09NGM Biopharmaceuticals: How They Changed A Dead End To A Crossroad
Apr 26Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth
Feb 21We're Hopeful That NGM Biopharmaceuticals (NASDAQ:NGM) Will Use Its Cash Wisely
Nov 08Companies Like NGM Biopharmaceuticals (NASDAQ:NGM) Are In A Position To Invest In Growth
Jul 09NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 06We're Not Very Worried About NGM Biopharmaceuticals' (NASDAQ:NGM) Cash Burn Rate
Mar 02Update: NGM Biopharmaceuticals (NASDAQ:NGM) Stock Gained 56% In The Last Year
Jan 26
NGM Bio gives update on 2021 plans and data timeline
Jan 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$142m |
| Sep 30 2023 | n/a | n/a | -US$151m |
| Jun 30 2023 | n/a | n/a | -US$170m |
| Mar 31 2023 | n/a | n/a | -US$178m |
| Dec 31 2022 | US$6m | US$610k | -US$163m |
| Sep 30 2022 | n/a | n/a | -US$153m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$125m |
| Dec 31 2021 | US$10m | US$580k | -US$120m |
| Sep 30 2021 | n/a | n/a | -US$121m |
| Jun 30 2021 | n/a | n/a | -US$122m |
| Mar 31 2021 | n/a | n/a | -US$111m |
| Dec 31 2020 | US$5m | US$525k | -US$102m |
| Sep 30 2020 | n/a | n/a | -US$90m |
| Jun 30 2020 | n/a | n/a | -US$72m |
| Mar 31 2020 | n/a | n/a | -US$54m |
| Dec 31 2019 | US$2m | US$490k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$13m |
| Jun 30 2019 | n/a | n/a | -US$9m |
| Mar 31 2019 | n/a | n/a | -US$5m |
| Dec 31 2018 | US$4m | US$413k | -US$493k |
Compensación vs. Mercado: La compensación total de David($USD5.93M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD677.87K).
Compensación vs. Ingresos: La compensación de David ha sido consistente con los resultados de la empresa en el último año.
CEO
David Woodhouse (52 yo)
5.6yrs
Permanencia
US$5,933,500
Compensación
Dr. David J. Woodhouse, Ph D., has been an Independent Director of Surrozen, Inc. since September 2020. Dr. Woodhouse joined the Surrozen, Inc. in September 2020.Dr. Woodhouse served as Acting Chief Finan...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman of the Board of Directors | 13.5yrs | US$1.10m | 3.32% $ 4.3m | |
| CEO & Director | 5.6yrs | US$5.93m | 0.14% $ 179.3k | |
| Senior VP | 4.5yrs | US$2.10m | 0.022% $ 28.7k | |
| Chief Medical Officer & Executive VP | 5.1yrs | US$2.73m | 0.017% $ 22.3k | |
| Chief Financial Officer | 1.3yrs | sin datos | sin datos | |
| VP, Corporate Controller & Principal Accounting Officer | less than a year | sin datos | 0.011% $ 13.8k | |
| Chief Scientific Officer | 1.3yrs | sin datos | sin datos | |
| Director of People & Culture | less than a year | sin datos | sin datos | |
| Head of Business Development | 1.8yrs | sin datos | sin datos | |
| Senior Director & Head of Biology | 1.3yrs | sin datos | sin datos | |
| Senior Vice President of CMC & Process Development | less than a year | sin datos | sin datos |
1.3yrs
Permanencia media
56.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de NGM no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman of the Board of Directors | 13.5yrs | US$1.10m | 3.32% $ 4.3m | |
| CEO & Director | 5.6yrs | US$5.93m | 0.14% $ 179.3k | |
| Special Advisor | no data | sin datos | sin datos | |
| Special Advisor | no data | sin datos | sin datos | |
| Lead Independent Director | 5.6yrs | US$270.23k | 19.87% $ 25.5m | |
| Chairman of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 2.8yrs | US$250.00k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$273.09k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 5.7yrs | US$265.00k | 0.0084% $ 10.8k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
5.6yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de NGM se considera experimentada (5.6 años de antigüedad promedio).